Benitec Biopharma Inc <BNTC.O>: Wedbush initiates coverage with outperform rating; target price $16
BNTC•Related News
HBT Financial, Inc <HBT.O>: Raymond James raises target price to $38 from $31
HBT•
US Stocks-Nasdaq futures slide as AI worries mount ahead of pivotal earnings
QQQ•
TFI International Inc <TFII.TO>: Scotiabank raises target price to C$263 from C$260
TFII•
Kazia Therapeutics files provisional patent for strategy to prevent metastatic recurrence in triple-negative breast cancer
KZIA•
Nasdaq trade halt continues <PC.O> reason not available at 07:30 AM
PC•